Discovery of a novel small molecule PT109 with multi-targeted effects against Alzheimer's disease in vitro and in vivo

2020/07/13 by Qiuhe Chen, Yalin Tu, Shinghung Mak +12 · 3 citations
Medicine · #Cholinesterase and Neurodegenerative Diseases #Alzheimer's disease research and treatments #Medicinal Plants and Neuroprotection

paper · doi:10.1016/j.ejphar.2020.173361

Citations

• RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
• Microglia in Alzheimer’s disease

Cited by

• Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway. [europepmc]
• Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials. [europepmc]
• JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties. [europepmc]